Am. Stadelmann et al., EXPRESSION OF MESSENGER-RNA FOR VASOACTIVE-INTESTINAL-PEPTIDE IN RAT SMALL-INTESTINE, Molecular and cellular endocrinology, 116(1), 1996, pp. 31-37
Transplantation of small intestine is a neural model that permits stud
ies of expression of the neuropeptide, vasoactive intestinal peptide;
following extrinsic denervation, transection of intrinsic neural pathw
ays, and an ischemic interval. Tissue levels of vasoactive intestinal
peptide were examined at 3 months in ileum from a sham operation, in i
leum after resection of proximal small intestine, in ileum after resec
tion of proximal small intestine and extrinsic denervation, in ileum a
fter resection of proximal small intestine and 30 min of ischemia, and
in ileum obtained 3 months after ileal isografting in Lewis-to-Lewis
combinations. Vasoactive intestinal peptide levels were increased in t
ransplanted rat ileum, resection controls, denervation controls, and i
schemic controls compared to sham-operated ileum (pANOVA < 0.01). The
increased levels of this peptide were highest in denervation controls
and lowest in ischemic controls. Northern blot analysis using rat vaso
active intestinal peptide cDNA identified a single 1.7-kb transcript i
n normal and transplanted rat ileum. The density of vasoactive intesti
nal peptide transcripts was increased in transplanted ileum (8450 +/-
540) compared to normal ileum (5790 +/- 620) (P < 0.01), and the ratio
of this transcript to glyceraldehyde-3-phosphate dehydrogenase densit
y units was also increased in transplanted ileum (0.81 +/- 0.08) compa
red to normal ileum (0.40 +/- 0.07; P < 0.01). Enhanced transcriptiona
l regulation was the likely mechanism for increased tissue vasoactive
intestinal peptide. The increased tissue levels appeared to be a respo
nse to extrinsic denervation and transection of intrinsic neural pathw
ays, while an ischemic interval appeared to decrease tissue levels of
the peptide.